Chronic cerebral ischemia and dizziness

Mendelevich E.G.

doi:https://doi.org/10.17116/jnevro202212203122

Close metadata

Recommended articles:

Brain microstructural abnormalities assessed by diffusion kurtosis MRI in patients with focal temporal lobe epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):171-177

Modern aspects of chronic cerebral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113

Experience of using reamberin for correction of cognitive status in patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):84-88

Quantitative and qualitative assessment of the complete blood count in patients with obstructive sleep apnea and chronic ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):95-102

FA2H gene-associated spastic paraplegia (SPG35) — familial case with late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):137-144

Resolution of the expert council «Possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders». Russian Journal of Preventive Medicine. 2024;(11):85-93

Magnetic resonance imaging and PET/CT with 11C-methionine for primary central nervous system vasculitis. Burdenko's Journal of Neurosurgery. 2024;(6):71-76

Features of the temporomandibular joint morphology and function in the adults with different growth patterns. Stomatology. 2025;(1):29-36

Meniere’s disease and vestibular migraine: differential diagnostics and treatment. Russian Bulletin of Otorhinolaryngology. 2025;(1):57-63

Remote technologies in the management of patients with vestibular pathology. Russian Bulletin of Otorhinolaryngology. 2025;(3):53-59

Abstract:

Older age is characterized by a high prevalence of dizziness/vertigo, including various variants — central and peripheral vestibular disorders, feelings of instability, balance disorders. High frequency of dizziness and chronic cerebral ischemia in the elderly age category supports traditional ideas about relationship of these pathologies. However, there is a known overestimation of Chronic cerebral ischemia as a cause dizziness of and unclear mechanisms of this process. With a high prevalence of vestibular disorders in the elderly and their verification, in some cases, the causes of dizziness cannot be identified. This has prompted the designation of this type of dizziness as «unexplained». The article cites recent studies demonstrating a relationship between «unexplained» dizziness and chronic cerebrovascular pathology. The theories explaining the mechanisms of this association are proposed. The role of choline alphoscerate in the treatment of dizziness in Chronic cerebral ischemia has been demonstrated. The mechanisms of positive effect of choline alphocerate and prospects of its using.

Keywords:

dizziness

chronic cerebral ischemia

white matter hyperintensity

MRI

choline alfoscerate

Cereton

Authors:

Mendelevich E.G.

Kazan State Medical University

ORCID: 0000-0002-6829-7942

Received:

25.02.2022

Accepted:

05.03.2022

Close metadata

References:

Shibuya M, Costa C, Leandro L, Lucato T. Neuroimaging in cerebral small vessel disease. Update and new concepts. Dement Neuropsychol. 2017;11(4):3-9. https://doi.org/10.1590/1980-57642016dn11-040002
Metacohorts for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimer’s & Dementia. 2016;12:1235-1249. https://doi.org/10.1016/j.jalz.2016.06.004
Wardlaw J, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497. https://doi.org/10.1016/S1474-4422(13)70060-7
Tuladhar A, van Dijk E, Zwiers M, van Norden A, de Laat K, Shumskaya E, Norris D, de Leeuw F. Structural network connectivity and cognition in cerebral small vessel disease. Hum Brain Mapp. 2016;37(1):300-310. https://doi.org/10.1002/hbm.23032
Jonsson R, Sixt E, Landahl S, Rosenhall U. Prevalence of dizziness and vertigo in an urban elderly population. J Vest Res. 2004;14:47-52. https://doi.org/10.3233/VES-2004-14105
Brandt T, Dieterich M. Vertigo and dizziness: common complains. London: Springer; 2004.
Parfenov VA, Antonenko LM. Major diseases manifesting by vestibular vertigo: Treatment and rehabilitation. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(2):56-60. (In Russ.). https://doi.org/10.14412/2074-2711-2015-2-56-60
Colledge N, Barr-Hamilton R. Evaluation of investigations to diagnose the cause of dizziness in elderly: a community based controlled study. BMJ. 1996;28:313(7060):788-792. https://doi.org/10.1136/bmj.313.7060.788
Sloane P, Blazer D, George LK. Dizziness in a community elderly population. J Am Geriatr Soc. 1989;37:101-108. https://doi.org/10.1111/j.1532-5415.1989.tb05867.x
Furman JM, Yael Raz, Susan L. Dizzinesss and vertigo. Whitney Curr Opin Otolaryngol Head Neck Surg. 2010;18(5):386-391. https://doi.org/10.1097/MOO.0b013e32833ce5a6
Jonsson R, Sixt E, Landahl S, Rosenhall U. Prevalence of dizziness and vertigo in an urban elderly population. J Vestib Res. 2004;14:47-55. https://doi.org/10.3233/VES-2004-14105
Jahn K, Kressig R, Bridenbaugh S, et al. Dizziness and unstable gait in old age — etiology, diagnosis and treatment. Dtsch Arztebl Int. 2015;112:387-393. https://doi.org/10.3238/arztebl.2015.0387
Snijders A, van de Warrenburg B, Giladi N, Bloem B. Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol. 2007;6:63-74. https://doi.org/10.1016/S1474-4422(06)70678-0
Mahlknecht P, Kiechl S, Bloem B, Willeit J, Scherfler C, Gasperi A, et al. Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study. PLoS One. 2013;8:e69627. https://doi.org/10.1371/journal.pone.0069627
Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, et al. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology. 2008;70:935-942. https://doi.org/10.1212/01.wnl.0000305959.46197.e6
Ahmad H, Cerchiai N, Mancuso M, et al. Are white matter abnormalities associated with «unexplained dizziness»? J Neurol Sci. 2015;358:428-431. https://doi.org/10.1016/j.jns.2015.09.006
Colledge N. Magnetic resonance brain imaging in people with dizziness: a comparison with non-dizzy people. J Neurol Neurosurg Psychiatry. 2002;72:587-589. https://doi.org/10.1136/jnnp.72.5.587
Adamec I. Predictors of development of chronic vestibular insufficiency after vestibular neuritis. J Neurol Sci. 2014;347(1-2):224-228. https://doi.org/10.1016/j.jns.2014.10.001
Okroglic S, Widmann CN, Urbach H, et al. Clinical symptoms and risk factors in cerebral microangiopathy patients. PLoS One. 2013;8(2):e53455. https://doi.org/10.1371/journal.pone.0053455
Sibolt G, Curtze S, Melkas S, et al. White matter lesions are associated with hospital admissions because of hip-fractures and trauma a er ischemic stroke. Stroke. 2014;45:2948-2951. https://doi.org/10.1161/STROKEAHA.114.006116
Cerchiai N, Mancuso M, Navari E, et al. Aging with Cerebral Small Vessel Disease and Dizziness: Importance of Undiagnosed Vestibular Disorders. Front Neurol. 2017;8:241-249. https://doi.org/10.3389/fneur.2017.00241
Kaski D, Rust H, Ibitoye R, et al. Theoretical framework for «unexplained» dizziness in the elderly: The role of small vessel disease. Prog Brain Res. 2019;248:225-240. https://doi.org/10.1016/bs.pbr.2019.04.009
Kaski D. Neurological update: dizziness. J Neurol. 2020;267:1864-1869. https://doi.org/10.1007/s00415-020-09748-w
Kattah JC, Talkad AV, Wang DZ, et al. HINTS to diagnose stroke in the acute vestibular syndrome. Stroke. 2009;40:3504-3510. https://doi.org/10.1161/STROKEAHA.109.551234
Ibitoye R, Castro P, Desowska A, et al. Dizziness in the elderly. Clin Neurophysiol. 2021;132(11):2751-762. https://doi.org/10.1016/j.clinph.2021.07.027
Pizova NV. The use of cereton in patients with chronic brain ischemia and moderate cognitive impairment. S.S. Korsakov J Neurol Psychiatry. 2014;112(12):78-82. (In Russ.). https://doi.org/10.17116/jnevro201411412178-83
Tayebati S, Di Tullio M, Tomassoni D. et al. Neuroprotective effect of treatment with galantamine and choline alphoscerate on brain microanatomy in spontaneously hypertensive rats. J Neurol Sci. 2009;15:283:1-2:187-194. https://doi.org/10.1016/j.jns.2009.02.349
Dzyak LA, Tsurkalenko EO. The role of cholinergic deficiency in the pathogenesis of neuropsychiatric diseases. Int Neurol J. 2019;3(105):33-45. (In Russ.).
Mendelevich EG, Surzenko IL, Dunin DN, Bogdanov EI. Cereton in the treatment of cognitive impairment in patients with dyscirculatory and post-traumatic encephalopathy. RMZh. 2009;5(17):384-387. (In Russ.).
Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mech Ageing Dev. 2001;122(16):2041-2055. https://doi.org/10.1016/s0047-6374(01)00312-8
Scapicchio P. Revisiting choline alphoscerate profile: a new, perspective, role in dementia? Int J Neurosci. 2013;123(7):444-449. https://doi.org/10.3109/00207454.2013.765870
Amenta F, Carotenuto A, Fasanaro AM, et al. Analisi comparativa della sicurezza/efficacia degli inibitori delle colinesterasi e del precursore colinergico colina alfoscerato nelle demenze ad esordio nell’eta adulta. G Gerontol. 2010;58:64-68.
Odinak MM, Voznyuk IA, Piradov MA, et al. Multicenter (pilot) study of the effectiveness of Gliatilin in acute ischemic stroke. Ann Clin Exp Neurol. 2010;4(1):20-29. (In Russ.). https://doi.org/10.17116/jnevro2020120061144
Monzani D, Genovese E, Marrara A, et al. Stimulation of the cholinergic neurotransmissions enhances the ef cacy of vestibular rehabilitation. Acta Otorhinolaryngol. 2010;30:11-19.